These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30901161)

  • 1. Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo.
    Read C; Yang P; Kuc RE; Nyimanu D; Williams TL; Glen RC; Holt LJ; Arulanantham H; Smart A; Davenport AP; Maguire JJ
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6():96-103. PubMed ID: 30901161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac action of the first G protein biased small molecule apelin agonist.
    Read C; Fitzpatrick CM; Yang P; Kuc RE; Maguire JJ; Glen RC; Foster RE; Davenport AP
    Biochem Pharmacol; 2016 Sep; 116():63-72. PubMed ID: 27475715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
    Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
    Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist.
    Brame AL; Maguire JJ; Yang P; Dyson A; Torella R; Cheriyan J; Singer M; Glen RC; Wilkinson IB; Davenport AP
    Hypertension; 2015 Apr; 65(4):834-40. PubMed ID: 25712721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gαi-biased apelin analog protects against isoproterenol-induced myocardial dysfunction in rats.
    Coquerel D; Delile E; Dumont L; Chagnon F; Murza A; Sainsily X; Salvail D; Sarret P; Marsault E; Auger-Messier M; Lesur O
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1646-H1656. PubMed ID: 33635165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pyr
    Yang P; Kuc RE; Brame AL; Dyson A; Singer M; Glen RC; Cheriyan J; Wilkinson IB; Davenport AP; Maguire JJ
    Front Neurosci; 2017; 11():92. PubMed ID: 28293165
    [No Abstract]   [Full Text] [Related]  

  • 7. Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor.
    Nyimanu D; Kuc RE; Williams TL; Bednarek M; Ambery P; Jermutus L; Maguire JJ; Davenport AP
    Peptides; 2019 Nov; 121():170139. PubMed ID: 31472173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.
    Yang P; Read C; Kuc RE; Buonincontri G; Southwood M; Torella R; Upton PD; Crosby A; Sawiak SJ; Carpenter TA; Glen RC; Morrell NW; Maguire JJ; Davenport AP
    Circulation; 2017 Mar; 135(12):1160-1173. PubMed ID: 28137936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
    Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
    Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension.
    Rostamzadeh F; Najafipour H; Yeganeh-Hajahmadi M; Joukar S
    Clin Exp Pharmacol Physiol; 2018 Feb; 45(2):187-197. PubMed ID: 28945940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of novel macrocyclic biased apelin receptor agonists.
    Murza A; Sainsily X; Côté J; Bruneau-Cossette L; Besserer-Offroy É; Longpré JM; Leduc R; Dumaine R; Lesur O; Auger-Messier M; Sarret P; Marsault É
    Org Biomol Chem; 2017 Jan; 15(2):449-458. PubMed ID: 27924341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure.
    Pang H; Han B; Yu T; Zong Z
    Int J Mol Med; 2014 Sep; 34(3):756-64. PubMed ID: 24993609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenyl Acid Derivatives as APJ Receptor Agonists.
    Su S; Clarke A; Han Y; Chao HJ; Bostwick J; Schumacher W; Wang T; Yan M; Hsu MY; Simmons E; Luk C; Xu C; Dabros M; Galella M; Onorato J; Gordon D; Wexler R; Gargalovic PS; Lawrence RM
    J Med Chem; 2019 Nov; 62(22):10456-10465. PubMed ID: 31724863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension.
    Yang P; Read C; Kuc RE; Nyimanu D; Williams TL; Crosby A; Buonincontri G; Southwood M; Sawiak SJ; Glen RC; Morrell NW; Davenport AP; Maguire JJ
    Br J Pharmacol; 2019 May; 176(9):1206-1221. PubMed ID: 30710493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin receptor expression in ischemic and non- ischemic kidneys and cardiovascular responses to apelin in chronic two-kidney-one-clip hypertension in rats.
    Najafipour H; Soltani Hekmat A; Nekooian AA; Esmaeili-Mahani S
    Regul Pept; 2012 Oct; 178(1-3):43-50. PubMed ID: 22796316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure.
    Japp AG; Cruden NL; Barnes G; van Gemeren N; Mathews J; Adamson J; Johnston NR; Denvir MA; Megson IL; Flapan AD; Newby DE
    Circulation; 2010 Apr; 121(16):1818-27. PubMed ID: 20385929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility.
    Szokodi I; Tavi P; Földes G; Voutilainen-Myllylä S; Ilves M; Tokola H; Pikkarainen S; Piuhola J; Rysä J; Tóth M; Ruskoaho H
    Circ Res; 2002 Sep; 91(5):434-40. PubMed ID: 12215493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin V1a receptors mediate the hypertensive effects of [Pyr
    Griffiths PR; Lolait SJ; Harris LE; Paton JFR; O'Carroll AM
    J Physiol; 2017 Jun; 595(11):3303-3318. PubMed ID: 28255983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate.
    Johnson JA; Kim SH; Jiang J; Phillips M; Schumacher WA; Bostwick JS; Gargalovic PS; Onorato JM; Luk CE; Generaux C; He Y; Chen XQ; Xu C; Galella MA; Wang T; Gordon DA; Wexler RR; Finlay HJ
    J Med Chem; 2021 Mar; 64(6):3086-3099. PubMed ID: 33689340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
    Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
    J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.